院長:詹宏裕醫師
其他身心精神醫療專業職務
精神健康基金會桃園分會副會長
台灣精神專科醫師筆試出題委員及口試委員
------------------
學歷
高雄醫學院醫學系畢業
台大預防醫學研究所碩士畢業
英國倫敦國王學院精神醫療服務碩士畢業
台大預防醫學研究所博士畢業
------------------
經歷
衛生福利部桃園療養院副院長
台大醫院精神醫學部兼任主治醫師
台灣大學醫學院兼任助理教授
中央健康保險署健保審查委員
台灣精神醫學會精神專科醫師甄審小組召集人
台灣精神醫學會理事
------------------
榮譽事蹟
事蹟名稱 頒獎單位 獲獎年
十大溫暖抗憂醫師 肯愛社會服務協會 2010年
優良醫師 衛生福利部 2015年
優良醫師 桃園市政府 2020年
資深典範醫師 衛生福利部 2021年
三等衛生獎章 衛生福利部 2021年
二等服務獎章 行政院 2022年
詹宏裕院長目前擔任27種SCI (Science Citation Index,科學引文索引) 國際期刊的論文審核專家,列舉如下:
1.Schizophrenia Search since 2008
(SCI paper)
2.CNS Neuroscience and Therapeutics
since 2009 (SCI paper)
3.Journal of Clinical
Psychopharmacology since 2010 (SCI paper)
4.Psychiatry and Clinical
Neurosciences since 2011 (SCI paper)
5.Addiction Research & Theory
since 2013 (SCI paper)
6.Journal of the Formosan Medical
Association since 2013 (SCI paper)
7.Expert Opinion On Drug
Metabolism and Toxicology since 2014 (SCI paper)
8.Therapeutic Advances in
Psychopharmacology since 2014 (SCI paper)
9.Neurosciences since 2015 (SCI
paper)
10.BJPsych open since 2016 (SCI
paper)
11.Clinical Neurology and
Neurosurgery since 2017 (SCI paper)
12.Aging and mental health since
2017 (SCI paper)
13.BMJ open since 2018 (SCI paper)
15.International Journal of
Epidemiology since 2020 (SCI paper)
16.Saudi Pharmaceutical Journal since 2020 (SCI paper)
17.Psychiatry Research since 2020 (SCI paper)
18.CNS Spectrums since 221 (S0CI paper)
19.Advances in Therapy since 2022
(SCI paper)
20.Basic & Clinical Pharmacology & Toxicology since 2022 (SCI paper)
21.Epidemiology and Psychiatric Sciences since 2022 (SCI paper)
22.The Journal of Clinical Psychiatry since 2023 (SCI paper)
23.Journal of Translational Medicine since 2023 (SCI paper)
24.CNS Drugs since 2023 (S0CI paper)
25.Social Psychiatry and Psychiatric Epidemiology since 2023 (S0CI paper)
26.The Journal of Psychiatric Research since 2024 (SCI paper)
27.Journal of Affective disorders since 2024 (SCI paper)
近8年發表的SCI國際學術論文(Chan HY為詹宏裕院長的英文簡稱,*代表通訊作者,1代表共同第一作者)
1.
Chan
HY, Pan
YJ, Chen JJ, Chen CH. Time to Discontinuation of Second-Generation
Antipsychotics versus Haloperidol and Sulpiride in People with Schizophrenia: a
Naturalistic, Comparative Study. J Clin Psychopharmacol. 2017;37(1):13-20. (SCI
paper).
2.
Pan
YJ, Yeh LL, Chan HY, Chang CK. Transformation of excess mortality in
people with schizophrenia and bipolar disorder in Taiwan. Psychol Med. 2017:26:1-11.
(SCI paper) .
3.
Hung
YY, Chan HY,1 Pan YJ. Risk factors for readmission in
schizophrenia patients following involuntary admission. PLOS ONE. 2017;12(10):
e0186768. (SCI paper).
4.
Lin
YC, Lai CL, Chan HY*. The association between rehabilitation programs
and metabolic syndrome in chronic inpatients with schizophrenia. Psychiatry
Res. 2018;260(2):227-232. (SCI paper).
5.
Chan
CH, Chan HY,1 Chen YC. Switching Antipsychotic Treatment to
Aripiprazole in Psychotic Patients with Neuroleptic-induced Tardive Dyskinesia:
A 24-week Follow-up Study. Int Clin Psychopharmacol. 2018;33(3):155-162. (SCI
paper).
6.
Hsu
CC, Chan HY1*. Factors associated with prolonged length of
stay in the psychiatric emergency service. PLOS ONE. 2018; 13(8):e0202569. (SCI
paper).
7.
Pan
YJ, Kuo KH, Chan HY, Yeh LL. Cost-effectiveness and cost-utility
analysis of outpatient follow-up frequency in relation to three-year mortality
in discharged patients with bipolar disorder. Psychiatry Res. 2019;13(272):61-68.
(SCI paper).
8.
Lin
CH, Chen FC, Chan HY*, Hsu CC. Time to rehospitalization in
patients with schizophrenia receiving long-acting injectable antipsychotics or
oral antipsychotics. Int J Neuropsychopharmacol. 2019;22(9):541-547. (SCI
paper).
9.
Lin
AS, Chan HY, Peng YC, Chen WJ. Severity in sustained attention
impairment and clozapine-resistant schizophrenia: a retrospective study. BMC
Psychiatry. 2019;19(1):220. (SCI paper).
10. Chan HY, Lin YC, Lai CL, Hsu
CC. Is antipsychotic treatment associated with risk of pneumonia in people with
serious mental illness? The roles of severity of psychiatric symptoms and
global functioning. J Clin Psychopharmacol. 2019;39(5):434-440. (SCI paper).
11. Lin CH, Chen FC, Chan
HY*, Hsu CC. A Comparison of Long-Acting Injectable Antipsychotics with
Oral Antipsychotics on Time to Rehospitalization within One Year of Discharge
in Elderly Patients with Schizophrenia. Am J Geri Psychiatry. 2020;28(1):23-30.
(SCI paper).
12. Chan HY, Chen JJ, Pan YJ, Hsu
CC. Nicotine replacement therapy and healthy lifestyle psychoeducation for
smoking reduction in acute psychiatric inpatients: a cluster-randomized
parallel study. J Clin Psychopharmacol. 2020;40(2):149-156. (SCI paper).
13. Tien SC, Chan HY*,
Hsu CC. The Factors Associated with Inappropriate Prescription Patterns of
Benzodiazepines and Related Drugs among Patients with Dementia. Psychogeriatrics.
2020;20(4):447-457. (SCI paper).
14. Wu KH, Juan SC, Chan
CH, Chou SY, Chan HY*. Factors Affecting Changes of Cluster of
Differentiation 4 Cell Counts among Human Immunodeficiency Virus-Positive People
Who Inject Heroin and Receive Methadone Maintenance Treatment. J Addict Med.
2020 Dec;14(6):e310-e315. (SCI paper).
15. Lin CH, Chan HY*,
Chen FC, Hsu CC. Temporal trends in clozapine use at time of discharge among
people with schizophrenia at two public psychiatric hospitals in Taiwan,
2006–2017. Sci Rep. 2020;10: 17984. (SCI paper).
16. Jen YW, Hwang TJ, Chan
HY, Hsieh MH, Liu CC, Liu CM, Hwu HG, Kuo CH, Lin YT, Chien YL, Chen WJ.
Abnormally low prolactin levels in schizophrenia patients after switching to
aripiprazole in a randomized trial: a biomarker for rebound in psychotic
symptoms? BMC Psychiatry 2020; 20(1):552. (SCI paper).
17. Pan YJ, Yeh LL, Chan
HY, Chang CK. Excess mortality and shortened life expectancy in people with
major mental illnesses in Taiwan. Epidemiol Psychiatr Sci. 2020 Aug
14;29:e156. (SCI paper).
18. Chen C, Chan HY,
Yeh LL, Pan YJ. Longitudinal factors associated with mortality in older
patients with mood disorders. J Affect Disord. 2021;278(1):607-613. (SCI
paper).
19. Lin CH, Chan HY*,
Chen FC, Hsu CC. Time to rehospitalization in patients with bipolar mania
discharged on long-acting injectable or oral antipsychotics. J Affect Disord. 2021;279:292-298.
(SCI paper).
20. Lin CH, Chan HY*,
Chen FC, Hsu CC. Factors associated with laxative use in schizophrenia patients
treated with second-generation antipsychotics. Eur Neuropsychopharmacol. 2021; (43)139-146.
(SCI paper).
21. Wei LC, Chan HY*.
Relationship between choice of opioid agonist therapy and distance from
patients’ residences in Taiwan, 2012–2014. Am J Drug Alcohol Abuse 2021;47(5):590-598.
(SCI paper).
22. Tsai CH, Yu KT, Chan HY, Chan CH. Hashimoto’s encephalopathy presenting as catatonia in a bipolar patient. Asian J Psychiatry. 2021;66:102895.(SCI paper).
23. Wang XY, Chan HY,1 Lin CH. Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients with Schizophrenia: A 17-Year Retrospective Cohort Study. J Clin Psychopharmacol. 2022;42(2):133-139. (SCI paper).
24. Ma CH, Chan HY,
Hsieh MH, Liu CC, Liu CM, Hwu HG, Kuo CH, Chen WJ, Hwang TJ. Identifying
dopamine supersensitivity through a randomized controlled study of switching to
aripiprazole from other antipsychotic agents in patients with schizophrenia. Ther
Adv Psychopharmacol. 2022
Jan 28;12:20451253211064396. doi: 10.1177/20451253211064396. (SCI paper).
25. Lin CH, Chan HY*,
Wang FC, Hsu CC. Time to rehospitalization in involuntary patients with
schizophrenia discharged on long-acting injectable antipsychotics or oral
antipsychotics. Ther Adv Psychopharmacol. 2022 Mar
23;12:20451253221079165. doi: 10.1177/20451253221079165. (SCI
paper).
26. Cheng SW, Lue CW, Chan HY*, Chen CC, Hsu CC. Antipsychotic Prescription Patterns and Associated Factors among the Elderly with Psychiatric Illnesses. Int Clin Psychopharmacol. 2022;37(4):151-158. (SCI paper).
27. Lin YH, Wu CS, Liu CC, Kuo PH, Chan HY, Chen WJ. Comparative Effectiveness of Antipsychotics in Preventing Readmission for First-Admission Schizophrenia Patients in National Cohorts from 2001 to 2017 in Taiwan. Schizophr Bull. 2022;48(4):785-794. (SCI paper).
28. Lin CH, Lin HY, Lin TC, Chan HY*, Chen JJ. The relation between second-generation antipsychotics and laxative use in elderly patients with schizophrenia. Psychogeriatrics. 2022;22(5):718-727. (SCI paper).
29. Lin CH, Chan HY, Chen CC. Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019. J Affect Disord. 2022;318:386-392. (SCI paper).
30. Lin CH, Chan HY, Lin HY, Chen CC. Fourteen-year trends in the prescribing patterns of pediatric bipolar patients discharged from two public mental hospitals in Taiwan. Asia Pacific Psychiatry. 2023;15(1):e12525. (SCI paper).
31. Lin CH, Hunag CJ, Lin TC, Chan HY*, Chen JJ. Schizophrenia patients discharged on antipsychotic polypharmacy from a public psychiatric hospital in Taiwan, 2006-2021. Psychiatry Res. 2023 December;330.115575. (SCI paper).
32. Yu SC, Hwang TJ, Liu CM, Chan HY, ...,Chen WJ. Patients with first-episode psychosis in northern Taiwan: neurocognitive performance and niacin response profile in comparison with schizophrenia patients of different familial loadings and relationship with clinical features. BMC Psychiatry. 2024 Feb 22;24(1):155. (SCI paper).
33. Chen W, Wu CS, Liu CC, Kuo PH, Chan HY, ...,Chen WJ. In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan. JAMA Network Open. 2024 ;7(6):e2417006- (SCI paper).
34. Wang KC, Chan HY, .Yang WS, Huang YM, Ho YF, Hwang TJ. Cardiometabolic biomarkers and comorbid metabolic syndrome in schizophrenia: A cross-sectional study of long-term clozapine/olanzapine users. Asian J Psychiatry. Available online 13 September 2024, 104244 (SCI paper).
35. Lin CH, Hsu CC, Chan HY*, Chen JJ. Prescribing patterns for older age bipolar disorder patients discharged from two public mental hospitals in Taiwan, 2006-2019. Psychogeriatrics. Accepted on 12 September 2024. (SCI paper).
沒有留言:
張貼留言